Nootropic peptides for focus: hype vs. what studies show

What did @bakkebuilt actually say?

The creator held up a red pill and called it "the limitless pill," identifying it as diaxia, which he describes as "a peptide classified as a new tropic" originally developed for Alzheimer's and dementia patients. After nearly four months of use, he reports major improvements in focus, information retention, motivation, and even social skills. He also told viewers they "do not need to do blood work in order to get any peptides" when ordering through his affiliated clinic, Transcend.

That last line is the one that should stop you cold. A cognitive-enhancing peptide that requires zero medical screening before you purchase it is not a healthcare protocol. It's a supplement sales funnel with a lab coat painted on it. The focus and clarity testimonials are worth examining, but the no-bloodwork claim is where this video does real potential harm.

Does the science back this up?

Diaxia appears to be a brand or marketing name for dihexa, a synthetic peptide derived from angiotensin IV. The underlying research exists, but it is far thinner than this video implies. Most of the meaningful data comes from animal models, not human trials.

Dihexa was developed by researchers at Washington State University, and early work by McCoy et al. (2013, Journal of Pharmacology and Experimental Therapeutics) showed it significantly improved cognitive performance in rat models of Alzheimer's disease, partly by potentiating hepatocyte growth factor signaling and promoting synaptogenesis. That is genuinely interesting neuroscience. But interesting rodent data is not the same as proven human efficacy. There are no large-scale, peer-reviewed randomized controlled trials in humans confirming that dihexa improves focus, memory, or social cognition in healthy adults. The claim that it is "one of the best nootropics on the market" is marketing language, not a scientific conclusion. Zero head-to-head comparison trials exist to support that ranking.

What did they get wrong (or right)?

Credit where it's due: the creator correctly identifies diaxia as a peptide, and the general category of nootropic is a reasonable description. The Alzheimer's and dementia research connection is real, not invented. Those are accurate anchor points.

But several claims fall apart under scrutiny. Calling it "one of the best nootropics on the market" has no evidentiary basis in humans. Describing personal improvements in social skills as a drug effect is anecdotal self-reporting with no controls, no baseline measurement, and obvious expectation bias. After four months of use, he has no way to isolate dihexa as the cause of anything he's feeling.

The most problematic statement is the one about skipping bloodwork. Dihexa has shown pro-angiogenic properties in animal studies, meaning it may stimulate blood vessel growth. For someone with an undetected tumor or vascular condition, that mechanism is not trivially safe. Recommending people bypass any clinical screening before starting a compound with this profile is genuinely irresponsible, regardless of how the peptide ultimately performs in future trials.

What should you actually know?

Dihexa is a research peptide. That phrase carries real meaning. It is not FDA-approved for any indication. It is not a regulated drug with established human dosing, long-term safety data, or confirmed tolerability across different populations. Compounded versions sold through telehealth platforms exist in a regulatory gray zone and have not been shown to be bioequivalent to research-grade compounds used in studies.

The mechanism dihexa works through, HGF/c-Met signaling potentiation, is powerful enough that researchers take its off-target effects seriously. Roberts et al. have noted in preclinical literature that compounds acting on this pathway warrant caution precisely because the same signaling involved in synaptogenesis is involved in cell proliferation more broadly.

If you are experiencing genuine cognitive difficulties, focus problems, or memory concerns, those symptoms deserve a real clinical evaluation, including bloodwork, not a peptide subscription skipping screening. If you are a healthy adult curious about nootropics, the evidence base for dihexa in that population is essentially nonexistent right now.

What is the bottom line on this video?

The creator is enthusiastic, and his personal experience may be genuine. Placebo effects on focus and motivation are well-documented and substantial. But this video combines real-but-preliminary science, unverifiable personal testimonials, and an explicit instruction to bypass medical screening, and packages it as a recommendation to buy a specific product through his affiliate link. That combination earns serious skepticism. Watch the video for awareness that dihexa exists. Do not treat it as a reason to order anything without talking to a physician who has actually reviewed your health history.